Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haigang Geng

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Translational Medicine|December 28, 2024
Association of PD-1 + Treg/PD-1 + CD8 ratio and tertiary lymphoid structures with prognosis and response in advanced gastric cancer patients receiving preoperative treatmentXu Liu, Danhua Xu, Chengbei Zhou, et al.
Cancers|July 9, 2022
An Immune Signature for Risk Stratification and Therapeutic Prediction in Helicobacter pylori-Infected Gastric CancerHaigang Geng, Zhongyi Dong, Linmeng Zhang, et al.
Journal of Molecular and Cellular Cardiology|December 6, 2020
Inhibition of endoplasmic reticulum stress mediates the ameliorative effect of apelin on vascular calcificationYanqing Li, Yuqing Li, Ying Li, et al.
Cancer Gene Therapy|December 1, 2023
Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancerHaigang Geng, Ruolan Qian, Yiqing Zhong, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 24, 2025
PTEN loss and ERBB2/ERBB3-mediated AKT reactivation drive resistance to MET inhibition in MET-amplified hepatocellular carcinomaRuolan Qian, Yuchen Guo, Xiaolin Hu, et al.
Oncology Reports|May 16, 2025
DEPP1: A prognostic biomarker linked to stroma‑rich and immunosuppressive microenvironment, promoting oxaliplatin resistance in gastric cancerXudong Qiu, Tao Pan, Tian Kuang, et al.
Journal of Translational Medicine|March 5, 2025
IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironmentZhaorong Wu, Hongye Wang, Zhigang Zheng, et al.
Life Sciences|April 15, 2024
Targeting cellular senescence as a therapeutic vulnerability in gastric cancerHaigang Geng, Chen Huang, Lei Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 27, 2026
From paradox to target: IFN-β hijacks MEK signaling to drive a cell death-evading dormant phenotype in colorectal cancerYangyang Zhou, Haigang Geng, Yi Xu, et al.
Iscience|November 24, 2022
High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancerShouyu Ke, Feng Xie, Yixian Guo, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Translational Medicine|December 28, 2024
Association of PD-1 + Treg/PD-1 + CD8 ratio and tertiary lymphoid structures with prognosis and response in advanced gastric cancer patients receiving preoperative treatmentXu Liu, Danhua Xu, Chengbei Zhou, et al.
Cancers|July 9, 2022
An Immune Signature for Risk Stratification and Therapeutic Prediction in Helicobacter pylori-Infected Gastric CancerHaigang Geng, Zhongyi Dong, Linmeng Zhang, et al.
Journal of Molecular and Cellular Cardiology|December 6, 2020
Inhibition of endoplasmic reticulum stress mediates the ameliorative effect of apelin on vascular calcificationYanqing Li, Yuqing Li, Ying Li, et al.
Cancer Gene Therapy|December 1, 2023
Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancerHaigang Geng, Ruolan Qian, Yiqing Zhong, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 24, 2025
PTEN loss and ERBB2/ERBB3-mediated AKT reactivation drive resistance to MET inhibition in MET-amplified hepatocellular carcinomaRuolan Qian, Yuchen Guo, Xiaolin Hu, et al.
Oncology Reports|May 16, 2025
DEPP1: A prognostic biomarker linked to stroma‑rich and immunosuppressive microenvironment, promoting oxaliplatin resistance in gastric cancerXudong Qiu, Tao Pan, Tian Kuang, et al.
Journal of Translational Medicine|March 5, 2025
IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironmentZhaorong Wu, Hongye Wang, Zhigang Zheng, et al.
Life Sciences|April 15, 2024
Targeting cellular senescence as a therapeutic vulnerability in gastric cancerHaigang Geng, Chen Huang, Lei Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 27, 2026
From paradox to target: IFN-β hijacks MEK signaling to drive a cell death-evading dormant phenotype in colorectal cancerYangyang Zhou, Haigang Geng, Yi Xu, et al.
Iscience|November 24, 2022
High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancerShouyu Ke, Feng Xie, Yixian Guo, et al.
Pageof 3